INNV Investors Have Opportunity to Lead InnovAge Holding Corp. Securities Lawsuit
Glancy Prongay & Murray LLP announces a class action lawsuit opportunity for InnovAge Holding Corp investors following significant losses. The relevant period is the March 2021 IPO, with a lead plaintiff deadline of December 13, 2021. Allegations include failure to disclose inadequate services provided by InnovAge facilities and potential regulatory scrutiny from the Centers for Medicare and Medicaid Services, risking suspension of new enrollments. Investors are encouraged to contact GPM for more information on their rights and the lawsuit process.
- None.
- Failure to disclose inadequate services by facilities.
- Potential regulatory scrutiny from CMS leading to enrollment suspensions.
- Defendants' positive statements were materially misleading.
LOS ANGELES, Dec. 10, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ: INNV).
Relevant Period: March 2021 IPO
Lead Plaintiff Deadline: December 13, 2021
If you wish to serve as lead plaintiff of the InnovAge lawsuit, you can submit your contact information at www.glancylaw.com/cases/innovage-holding-corp/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
The complaint filed alleges that the defendants failed to disclose to investors: (1) that certain of InnovAge's facilities failed to provide covered services, provide accessible and adequate services, manage participants' medical situations, and oversee use of specialists; (2) that, as a result, the Company was reasonably likely to be subject to regulatory scrutiny, including by the Centers for Medicare and Medicaid Services; (3) that, as a result, there as a significant risk that CMS would suspend new enrollments pending an audit of the Company's services; and (4) that, as a result of the foregoing, the defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Follow us for updates on LinkedIn, Twitter, or Facebook.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View original content to download multimedia:https://www.prnewswire.com/news-releases/innv-investors-have-opportunity-to-lead-innovage-holding-corp-securities--lawsuit-301441686.html
SOURCE Glancy Prongay & Murray LLP
FAQ
What is the InnovAge Holding Corp securities lawsuit about?
What is the lead plaintiff deadline for the InnovAge class action lawsuit?
How can I participate in the InnovAge securities fraud class action?
What risks does InnovAge face related to the lawsuit?
